r 56865 has been researched along with lysophosphatidylcholines in 2 studies
| Studies (r 56865) | Trials (r 56865) | Recent Studies (post-2010) (r 56865) | Studies (lysophosphatidylcholines) | Trials (lysophosphatidylcholines) | Recent Studies (post-2010) (lysophosphatidylcholines) |
|---|---|---|---|---|---|
| 72 | 1 | 0 | 5,058 | 39 | 976 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borgers, M; Geerts, H; Ver Donck, L; Verellen, G | 1 |
| Borgers, M; Ver Donck, L | 1 |
2 other study(ies) available for r 56865 and lysophosphatidylcholines
| Article | Year |
|---|---|
Lysophosphatidylcholine-induced Ca(2+)-overload in isolated cardiomyocytes and effect of cytoprotective drugs.
Topics: Animals; Benzothiazoles; Calcium; Flunarizine; Heart; Histocytochemistry; In Vitro Techniques; Intracellular Fluid; Ion Transport; Lysophosphatidylcholines; Microscopy, Electron; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Piperidines; Rabbits; Thiazoles | 1992 |
Myocardial protection by R 56865: a new principle based on prevention of ion channel pathology.
Topics: Animals; Benzothiazoles; Calcium; Cardiomyopathies; Heart; Lysophosphatidylcholines; Myocardial Contraction; Ouabain; Oxygen; Piperidines; Rabbits; Rats; Singlet Oxygen; Sodium; Sodium Channels; Tetrodotoxin; Thiazoles; Veratridine | 1991 |